Shandong Sinobioway Biomedicine (002581.SZ) announced that the company's board of directors recently received a resignation letter from the company's Chief Financial Officer, Liu Yangjun...
According to the Zhitong Finance APP, Shandong Sinobioway Biomedicine (002581.SZ) announced that the company's board of directors recently received a written resignation report submitted by the company's Chief Financial Officer, Liu Yangjun, who is resigning for personal reasons. After resigning, he will not hold any position in the company or its holding subsidiaries.
The company held the 30th meeting of the fifth board of directors on December 4, 2024, and approved the proposal on the appointment of a Chief Financial Officer. To ensure the compliant running and orderly management of the company's financial work, and after the nomination by the company's general manager, audit committee review, nomination committee qualification examination, and approval by the company's board of directors, it was agreed to appoint Ms. Zhou Ting as the company's Chief Financial Officer, with a term starting from the approval date of the 30th meeting of the fifth board of directors until the end of the term of the fifth board of directors.
